Table 3.
Posttransplant outcomes
| Primary outcome | ||||
|---|---|---|---|---|
| Parameter | FEV1/FVC <0.70 (n=63) | FEV1/FVC ≥0.70 (n=196) | HR | 95% CI |
| 30-day follow-up mortality, n (%) | 6 (9.5%) | 5 (2.6%) | 3.79 | 1.16, 12.40 |
| 1-year follow-up mortality, n (%) | 26 (41.3%) | 28(14.3%) | 3.48 | 2.04, 5.94 |
| 2-year follow-up mortality, n (%) | 30 (47.6%) | 33 (16.8%) | 3.50 | 2.13, 5.75 |
| 5-year follow-up mortality, n (%) | 40 (63.5%) | 41 (20.9%) | 4.13 | 2.67, 6.40 |
|
| ||||
| Secondary outcomes | ||||
|
| ||||
| Parameter | FEV1/FVC <0.70 (n=63) | FEV1/FVC ≥0.70 (n=196) | Difference | 95% CI |
|
| ||||
| Incidence of tracheostomy after HTX, n (%) | 16 (25.4%) | 8 (4.1%) | 21.3% | 10.2%, 32.4% |
| Time to extubation after HTX (days), mean ± SD | 13.8±23.9 | 4.1±4.5 | 9.7 days | 3.6, 15.8 days |
| Length of initial ICU stay (days), mean ± SD | 33.5±31.9 | 20.0±22.1 | 13.5 days | 4.8, 22.2 days |
| Length of initial hospital stay (days), mean ± SD | 52.0±30.8 | 43.4±22.6 | 8.6 days | 0.2, 17.0 days |
| 30-day follow-up occurrence of AF, n (%) | 12 (19.0%) | 16 (8.2%) | 10.8% | 0.4%, 21.2% |
Abbreviations: AF, atrial fibrillation; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; FEV1/FCV, Tiffeneau index; HTX, heart transplantation; ICU, intensive care unit.